Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

Modern management of lymphocyte predominant Hodgkin lymphoma

(2013) Katharine H. Xing et al.   BRITISH JOURNAL OF HAEMATOLOGY

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

(2011) K. J. Savage et al.   BLOOD

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

(2011) D. A. Eichenauer et al.   BLOOD

Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma

(2010) Mubarak Al-Mansour et al.   JOURNAL OF CLINICAL ONCOLOGY

Nodular, lymphocyte-predominant Hodgkin lymphoma

(2009) Irene Biasoli et al.   CANCER

What Is the Appropriate Systemic Chemotherapy for Lymphocyte-Predominant Hodgkin's Lymphoma?

(2009) George P. Canellos et al.   JOURNAL OF CLINICAL ONCOLOGY

Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up

(2009) Ronald C. Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group

(2007) Lucia Nogová et al.   JOURNAL OF CLINICAL ONCOLOGY